Cargando…
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
Recombinant adeno-associated viruses are important vectors for retinal gene delivery. Currently utilized vectors have relatively slow onset and for efficient transduction it is necessary to deliver treatment subretinally, with the potential for damage to the retina. Amino-acid substitutions in the v...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880610/ https://www.ncbi.nlm.nih.gov/pubmed/24225638 http://dx.doi.org/10.1038/gt.2013.64 |
_version_ | 1782298097112580096 |
---|---|
author | Mowat, FM Gornik, KR Dinculescu, A Boye, SL Hauswirth, WW Petersen-Jones, SM Bartoe, JT |
author_facet | Mowat, FM Gornik, KR Dinculescu, A Boye, SL Hauswirth, WW Petersen-Jones, SM Bartoe, JT |
author_sort | Mowat, FM |
collection | PubMed |
description | Recombinant adeno-associated viruses are important vectors for retinal gene delivery. Currently utilized vectors have relatively slow onset and for efficient transduction it is necessary to deliver treatment subretinally, with the potential for damage to the retina. Amino-acid substitutions in the viral capsid improve efficiency in rodent eyes by evading host responses. As dogs are important large animal models for human retinitis pigmentosa, we evaluated the speed and efficiency of retinal transduction using capsid-mutant vectors injected both subretinally and intravitreally. We evaluated AAV serotypes 2 and 8 with amino-acid substitutions of surface exposed capsid tyrosine residues. The chicken beta-actin promoter was used to drive green fluorescent protein expression. Twelve normal adult beagles were injected, 4 dogs received intravitreal injections, 8 dogs received subretinal injections. Capsid-mutant viruses tested included AAV2(quad Y-F) (intravitreal and subretinal), and self-complementary scAAV8(Y733F) (subretinal only). Contralateral control eyes received injections of scAAV5 (subretinal) or scAAV2 (intravitreal). Subretinally delivered vectors had a faster expression onset than intravitreally delivered vectors. Subretinally delivered scAAV8(Y733F) had a faster onset of expression than scAAV5. All subretinally injected vector types transduced the outer retina with high efficiency, and the inner retina with moderate efficiency. Intravitreally delivered AAV2(quad Y-F) had a marginally higher efficiency of transduction of both outer retinal and inner retinal cells than scAAV2. Because of their rapid expression onset and efficient transduction, subretinally delivered capsid-mutant AAV8 vectors may increase the efficacy of gene therapy treatment for rapid photoreceptor degenerative diseases. With further refinement, capsid-mutant AAV2 vectors show promise for retinal gene delivery from an intravitreal approach. |
format | Online Article Text |
id | pubmed-3880610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-38806102014-07-01 Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach Mowat, FM Gornik, KR Dinculescu, A Boye, SL Hauswirth, WW Petersen-Jones, SM Bartoe, JT Gene Ther Article Recombinant adeno-associated viruses are important vectors for retinal gene delivery. Currently utilized vectors have relatively slow onset and for efficient transduction it is necessary to deliver treatment subretinally, with the potential for damage to the retina. Amino-acid substitutions in the viral capsid improve efficiency in rodent eyes by evading host responses. As dogs are important large animal models for human retinitis pigmentosa, we evaluated the speed and efficiency of retinal transduction using capsid-mutant vectors injected both subretinally and intravitreally. We evaluated AAV serotypes 2 and 8 with amino-acid substitutions of surface exposed capsid tyrosine residues. The chicken beta-actin promoter was used to drive green fluorescent protein expression. Twelve normal adult beagles were injected, 4 dogs received intravitreal injections, 8 dogs received subretinal injections. Capsid-mutant viruses tested included AAV2(quad Y-F) (intravitreal and subretinal), and self-complementary scAAV8(Y733F) (subretinal only). Contralateral control eyes received injections of scAAV5 (subretinal) or scAAV2 (intravitreal). Subretinally delivered vectors had a faster expression onset than intravitreally delivered vectors. Subretinally delivered scAAV8(Y733F) had a faster onset of expression than scAAV5. All subretinally injected vector types transduced the outer retina with high efficiency, and the inner retina with moderate efficiency. Intravitreally delivered AAV2(quad Y-F) had a marginally higher efficiency of transduction of both outer retinal and inner retinal cells than scAAV2. Because of their rapid expression onset and efficient transduction, subretinally delivered capsid-mutant AAV8 vectors may increase the efficacy of gene therapy treatment for rapid photoreceptor degenerative diseases. With further refinement, capsid-mutant AAV2 vectors show promise for retinal gene delivery from an intravitreal approach. 2013-11-14 2014-01 /pmc/articles/PMC3880610/ /pubmed/24225638 http://dx.doi.org/10.1038/gt.2013.64 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Mowat, FM Gornik, KR Dinculescu, A Boye, SL Hauswirth, WW Petersen-Jones, SM Bartoe, JT Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach |
title | Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach |
title_full | Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach |
title_fullStr | Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach |
title_full_unstemmed | Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach |
title_short | Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach |
title_sort | tyrosine capsid-mutant aav vectors for gene delivery to the canine retina from a subretinal or intravitreal approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880610/ https://www.ncbi.nlm.nih.gov/pubmed/24225638 http://dx.doi.org/10.1038/gt.2013.64 |
work_keys_str_mv | AT mowatfm tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach AT gornikkr tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach AT dinculescua tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach AT boyesl tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach AT hauswirthww tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach AT petersenjonessm tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach AT bartoejt tyrosinecapsidmutantaavvectorsforgenedeliverytothecanineretinafromasubretinalorintravitrealapproach |